Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.
[adrenomyeloneuropathy]
Adrenoleukodystrophy
(
ALD
)
and
its
adult
variant
adrenomyeloneuropathy
(
AMN
)
are
X-
linked
diseases
associated
with
a
deficiency
in
the
peroxisomal
degradation
of
saturated
very
long
chain
fatty
acids
(
VLCFA
)
resulting
in
an
accumulation
of
VLCFA
in
the
central
and
peripheral
myelin
,
the
adrenal
cortex
and
the
testis
.
Adrenal
insufficiency
with
clinical
hypocortisolism
occurs
in
approximately
two
thirds
of
the
patients
with
AMN
.
We
studied
the
circulating
adrenal
hormones
17
alpha-hydroxyprogesterone
(
17
alpha-
OHP
)
,
androstenedione
and
dehydroepiandrosterone
sulphate
(
DHEAS
)
in
63
male
AMN
patients
(
age
17
-
65
years
)
and
the
DHEAS
serum
levels
in
95
healthy
male
controls
(
age
30
-
65
years
)
.
34
of
the
patients
presented
with
the
phenotype
of
only
spinal
cord
and
peripheral
nerve
disability
without
hypocortisolism
,
29
of
the
patients
presented
with
the
phenotype
of
either
additional
hypocortisolism
or
Addison
's
syndrome
only
.
Normal
17
alpha-
OHP
concentrations
were
found
in
all
patients
with
no
significant
difference
between
patients
without
and
with
hypocortisolism
(
6
.
07
+
/
-
0
.
61
nmol
/
l
and
4
.
76
+
/
-
0
.
37
nmol
/
l
)
.
Androstenedione
concentration
was
significantly
(
p
<
0
.
01
)
lower
in
patients
with
hypocortisolism
(
2
.
99
+
/
-
0
.
65
pmol
/
l
versus
5
.
71
+
/
-
0
.
68
pmol
/
l
)
.
As
serum
levels
of
DHEAS
are
agedependent
we
divided
the
two
groups
into
two
subgroups
each
(
subgroup
one
:
age
17
-
40
years
,
subgroup
two
:
age
41
-
65
years
)
.
The
DHEAS
concentration
of
patients
without
and
with
hypocortisolism
was
significantly
(
p
<
0
.
01
)
lower
in
both
subgroups
(
1
.
4
.
35
+
/
-
0
.
84
micromol
/
l
,
n
=
15
,
2
.
15
+
/
-
0
.
28
micromol
/
l
,
n
=
19
;
1
.
1
.
90
+
/
-
0
.
57
micromol
/
,
n
=
21
,
2
.
0
.
96
+
/
-
0
.
29
micromol
/
l
,
n
=
8
)
compared
to
controls
(
1
.
9
.
0
+
/
-
0
.
96
micromol
/
l
;
2
.
5
.
21
+
/
-
0
.
25
micromol
/
l
)
.
In
conclusion
,
androstenedione
and
DHEAS
serum
concentrations
are
subnormal
in
all
AMN
patients
and
may
therefore
serve
as
sensitive
markers
of
the
adrenal
function
in
adrenomyeloneuropathy
.
Diseases
Validation
Diseases presenting
"a deficiency in the peroxisomal degradation of saturated very long chain fatty acids"
symptom
adrenomyeloneuropathy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom